loader from loading.io

Quickfire: Intersectionality and Transgender Health

EMJ Podcast: Insights For Healthcare Professionals

Release Date: 09/07/2026

Deep Dive Part 1: The Cost of Better Health: How Should We Measure Success in Healthcare? show art Deep Dive Part 1: The Cost of Better Health: How Should We Measure Success in Healthcare?

EMJ Podcast: Insights For Healthcare Professionals

Anita Charlesworth joins host Saranya Ravindran to explore how the NHS measures success. From the limits of waiting-time targets to what “value” really means in healthcare, this episode unpacks how a smarter performance framework could better capture prevention, quality of life, and wider social outcomes. Timestamps: 00:00 – 01:02: Introduction 01:02 – 04:36: Measuring Outcomes 04:36 – 06:16: Overlooked Outcomes 06:16 – 07:19: Defining “Value” 07:19 – 10:31: Assessing Prevention 10:31 – 13:24: Encouraging Change

info_outline
Quickfire: The Cost of Better Health show art Quickfire: The Cost of Better Health

EMJ Podcast: Insights For Healthcare Professionals

In this rapid-fire episode, Anita Charlesworth answers key questions on the future of the NHS; from the biggest threat to its long-term sustainability to the most misunderstood concept in health economics. Perfect for listeners short on time but eager for a sharp, honest take on the state of the health service.

info_outline
Modern Lipidology in CVD Prevention: Delivering Prevention in Diverse Communities show art Modern Lipidology in CVD Prevention: Delivering Prevention in Diverse Communities

EMJ Podcast: Insights For Healthcare Professionals

In the final episode, Professor Devaki Nair explores how community-based screening programmes can improve cardiovascular risk detection among underserved populations. The discussion covers healthcare inequalities, barriers to lipid target achievement, and practical solutions for delivering cardiovascular prevention at scale. Timestamps: 00:00 – 00:53: Introduction 00:53 – 03:46: Community Initiatives 03:46 – 05:24: Undeserved Populations 05:24 – 06:52: Health Inequalities 06:52 – 10:16: Real-World Barriers 10:16 – 11:35: Future Prevention

info_outline
Modern Lipidology in CVD Prevention: The Rise of Lipoprotein(a) show art Modern Lipidology in CVD Prevention: The Rise of Lipoprotein(a)

EMJ Podcast: Insights For Healthcare Professionals

Why has Lipoprotein(a) emerged as one of the hottest topics in preventive cardiology? In Part 2, Professor Devaki Nair explains when clinicians should measure Lipoprotein(a), how elevated levels influence cardiovascular risk, and how emerging targeted therapies could transform prevention strategies in the coming decade. Timestamps: 00:00 – 00:40: Introduction 00:40 – 03:03: Lipoprotein(a)’s Rise 03:03 – 04:58: Measuring Lipoprotein(a) 04:58 – 08:04: Cardiovascular Risk 08:04 – 10:04: Targeted Therapies 09:28 – 12:12: Patient Referral

info_outline
Ebola: From Lessons to Action in Outbreak Preparedness show art Ebola: From Lessons to Action in Outbreak Preparedness

EMJ Podcast: Insights For Healthcare Professionals

info_outline
Modern Lipidology in CVD Prevention: Finding Families at Risk show art Modern Lipidology in CVD Prevention: Finding Families at Risk

EMJ Podcast: Insights For Healthcare Professionals

Professor Devaki Nair joins host Catherine Glass to discuss why familial hypercholesterolaemia remains underdiagnosed despite increasing awareness. Learn how genetic testing, cascade screening, and specialist lipid clinics are helping clinicians identify high-risk families earlier and improve the prevention of premature cardiovascular disease. Timestamps: 00:00 – 00:52: Introduction 00:52 – 04:50: Diagnostic Barriers 04:50 – 06:18: Genetic Testing 06:18 – 08:15: Screening Barriers 08:15 – 10:04: Lesson Learned 10:04 – 11:02: New Developments

info_outline
Quickfire: Modern Lipidology in CVD Prevention show art Quickfire: Modern Lipidology in CVD Prevention

EMJ Podcast: Insights For Healthcare Professionals

In this rapid-fire episode, Professor Devaki Nair answers key questions on cardiovascular prevention, cholesterol, Lipoprotein(a), familial hypercholesterolaemia, and the future of lipidology. Discover the biggest challenges, emerging trends, and opportunities shaping preventive cardiology in just a few minutes.

info_outline
FIT, Colonoscopy and the Future of Colorectal Cancer Screening: The Future of Screening and Early Diagnosis show art FIT, Colonoscopy and the Future of Colorectal Cancer Screening: The Future of Screening and Early Diagnosis

EMJ Podcast: Insights For Healthcare Professionals

In the final episode of this series on colorectal cancer screening, Matt Rutter explores the future of early diagnosis and prevention. From AI in endoscopy and personalised screening pathways to emerging technologies and unanswered research questions, this episode looks at how innovation could transform bowel cancer detection and prevention over the next decade. Timestamps: 58:09 – Innovations in colorectal cancer detection 05:10 – Personalised screening pathways 06:15 – Unanswered questions in colorectal cancer screening research 07:25 – One major change for healthcare systems...

info_outline
FIT, Colonoscopy and the Future of Colorectal Cancer Screening: FIT, Colonoscopy, and Quality in Detection show art FIT, Colonoscopy and the Future of Colorectal Cancer Screening: FIT, Colonoscopy, and Quality in Detection

EMJ Podcast: Insights For Healthcare Professionals

How do faecal immunochemical tests and colonoscopy work together to improve colorectal cancer detection? In Part 2, Matt Rutter discusses the importance of quality in endoscopy, including colonoscopy performance indicators, interval cancers, variation in outcomes, and the role of large-scale data in improving screening pathways. This episode highlights why quality improvement remains central to preventing colorectal cancer. Timestamps 01:08 – Endoscopy quality 03:18 – Colonoscopy quality indicators 04:56 – Variations between colonoscopy providers 08:05 – The National Endoscopy...

info_outline
Optimizing Outcomes for Central Nervous System Metastases in EGFR-Mutated Advanced Non-small Cell Lung Cancer show art Optimizing Outcomes for Central Nervous System Metastases in EGFR-Mutated Advanced Non-small Cell Lung Cancer

EMJ Podcast: Insights For Healthcare Professionals

This episode has been funded by AstraZeneca and is intended for healthcare professionals. All content has been developed independently by AMJ, and AstraZeneca has had no influence over the content of this podcast. The views expressed are those of the participating experts and do not necessarily reflect the views of AMJ or AstraZeneca. This material is intended for educational and scientific exchange purposes only. Thoracic medical oncologist Julia Rotow and neuro-oncologist David O. Kamson discuss how they manage central nervous system metastases in EGFR-mutated advanced non-small cell lung...

info_outline
 
More Episodes

In this rapid-fire episode, Tonia Poteat answers key questions on intersectionality, transgender health, and health equity. Discover what drives her work in LGBTQIA+ health, common misconceptions surrounding transgender healthcare, the biggest challenges facing transgender communities today, and the practical steps healthcare organisations can take to become more inclusive in just a few minutes.